RNA5SP471

Across TCGA pan-cancer cohorts, RNA5SP471 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP471 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP471 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNA5SP471 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

STAD, ESCA, and UCEC are the cancer types where RNA5SP471 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.683	0.322	.032	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.369	.027	18	view →
UCEC	OS	Tertile	All	0.725	0.875	.031	12	view →
KIRP	OS	Tertile	II,III,IV	0.199	0.771	.030	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNA5SP471–STAD (DFS)

Open the STAD breakdown →